Celon Pharma SA (CLN) — Cash Flow-to-Debt Ratio
Celon Pharma SA (CLN) has a Cash Flow-to-Debt Ratio of 0.39x as of December 2025, meaning its operating cash flow of zł36.63 Million could theoretically repay 0% of its total liabilities (zł94.21 Million) in one year. See CLN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Celon Pharma SA Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Celon Pharma SA across 14 annual periods. Also explore net asset growth rate of Celon Pharma SA to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Celon Pharma SA (2012–2025)
Year-by-year debt coverage analysis for Celon Pharma SA. For market capitalisation and broader financial context, see Celon Pharma SA market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | zł23.85 Million | zł94.21 Million | ▲ +320.1% |
| 2024 | -0.12x | zł-11.34 Million | zł98.59 Million | ▼ -71.2% |
| 2023 | -0.07x | zł-8.31 Million | zł123.75 Million | ▼ -84.8% |
| 2022 | -0.04x | zł-4.70 Million | zł129.29 Million | ▼ -112.7% |
| 2021 | 0.29x | zł43.95 Million | zł153.14 Million | ▲ +8.9% |
| 2020 | 0.26x | zł70.90 Million | zł268.97 Million | ▲ +863.6% |
| 2019 | -0.03x | zł-5.05 Million | zł146.31 Million | ▼ -114.1% |
| 2018 | 0.25x | zł28.24 Million | zł114.94 Million | ▼ -17.3% |
| 2017 | 0.30x | zł25.30 Million | zł85.20 Million | ▼ -11.1% |
| 2016 | 0.33x | zł20.65 Million | zł61.82 Million | ▼ -57.0% |
| 2015 | 0.78x | zł52.37 Million | zł67.47 Million | ▲ +14.1% |
| 2014 | 0.68x | zł24.36 Million | zł35.82 Million | ▲ +144.6% |
| 2013 | 0.28x | zł8.45 Million | zł30.39 Million | ▼ -69.3% |
| 2012 | 0.90x | zł12.87 Million | zł14.22 Million | — |